Daniel Devine & Co Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Biotechnology ETF
IBB
|
+$4.31M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.37M |
| 3 |
UnitedHealth
UNH
|
+$2.04M |
| 4 |
Apple
AAPL
|
+$354K |
| 5 |
iShares Global 100 ETF
IOO
|
+$347K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alerian MLP ETF
AMLP
|
+$211K |
| 2 |
AMJ
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
|
+$180K |
| 3 |
McDonald's
MCD
|
+$99.8K |
| 4 |
Abbott
ABT
|
+$23.6K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 9.91% |
| 2 | Industrials | 9.75% |
| 3 | Technology | 7.44% |
| 4 | Financials | 5.16% |
| 5 | Materials | 5% |
Similar funds
Daniel Devine & Co's Q3 2015 Portfolio in Review
As of Q3 2015, Daniel Devine & Co held 65 positions worth $141M, down 2.9% from $146M the previous quarter. Its ten largest holdings account for 57% of the portfolio.
Daniel Devine & Co deployed $9.59M of net new capital in Q3 2015, opening 3 new positions and adding to 17 existing holdings. Its largest new stake was iShares Biotechnology ETF: 35,910 shares worth $3.63M.
By sector, the portfolio is most concentrated in Healthcare at 9.9% of assets, up from 9% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was JP Morgan Alerian MLP Index ETN 5/24/24, an estimated $180K trimmed.
- Daniel Devine & Co's largest Q3 2015 buy was iShares Biotechnology ETF: 35,910 shares worth $3.63M.
- Daniel Devine & Co added most to State Street SPDR S&P 500 ETF Trust in Q3 2015, an estimated $2.37M increase.
- Daniel Devine & Co's biggest Q3 2015 reduction was JP Morgan Alerian MLP Index ETN 5/24/24, cutting an estimated $180K.
- Daniel Devine & Co fully exited Alerian MLP ETF in Q3 2015, selling an estimated $211K.
- Daniel Devine & Co's ten largest holdings make up 57% of its $141M portfolio in Q3 2015.
- Daniel Devine & Co opened 3 new positions and closed 1 in Q3 2015.
- Daniel Devine & Co's portfolio value fell 2.9% quarter-over-quarter to $141M.
Based on Daniel Devine & Co's 13F filing for Q3 2015, filed 15 Oct 2015.